Precision medicine is changing the way we treat cancer and biomarker testing is the key to opening the door to the types of personalized cancer treatments that can improve survival rates and quality of life. A.1673 and S.1196 requires all state-regulated insurance plans, including Medicaid, to cover biomarker testing when medically appropriate.
Read other patients who have benefited from biomarker testing in the New York Biomarker Testing Storybook found here.
To learn more about biomarker testing and the legislation to improve access to it go to https://www.fightcancer.org/new-york-biomarker-testing-campaign
